Unnamed: 0,title,date,stock,sentiment
58407.0,Aldeyra Therapeutics shares are trading higher after the company announced it reached an agreement with the FDA for the use of RASP as an objective sign for the treatment of dry eye disease.,2020-06-04 08:29:00-04:00,ALDX,positive
58408.0,Aldeyra Therapeutics Reaches Agreement With FDA For Use Of RASP As Objective Sign For Treatment Of Dry Eye Disease,2020-06-04 08:01:00-04:00,ALDX,positive
58409.0,65 Biggest Movers From Yesterday,2020-05-29 05:35:00-04:00,ALDX,neutral
58410.0,20 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-05-21 07:38:00-04:00,ALDX,neutral
58411.0,28 Stocks Moving in Thursday's Pre-Market Session,2020-05-21 07:17:00-04:00,ALDX,neutral
58412.0,70 Biggest Movers From Yesterday,2020-05-21 05:22:00-04:00,ALDX,neutral
58413.0,52 Stocks Moving In Wednesday's Mid-Day Session,2020-05-20 13:17:00-04:00,ALDX,neutral
58414.0,"The Daily Biotech Pulse: Aldeyra Jumps Into COVID-19 Drug Fray, FDA Nod For Myriad's Companion Diagnostic Test",2020-05-20 08:12:00-04:00,ALDX,neutral
58415.0,"Aldeyra Therapeutics shares are trading higher after the company announced it will advance its new HSP90 inhibitor, ADX-1612, to clinical testing for coronavirus.",2020-05-20 07:21:00-04:00,ALDX,positive
58416.0,30 Stocks Moving in Wednesday's Pre-Market Session,2020-05-20 07:16:00-04:00,ALDX,neutral
58417.0,"Aldeyra Therapeutics Says Will Advance ADX-1612, An Investigational New HSP90 Inhibitor With 'Potential Nanomolar Potency' Against SARS-CoV-2, To Clinical Testing For COVID-19 Coronavirus; ADX-629 Accepted For BARDA CoronaWatch Meeting",2020-05-20 07:02:00-04:00,ALDX,positive
58418.0,"Aldeyra Therapeutics Shares Halted, News Pending",2020-05-20 07:00:00-04:00,ALDX,positive
58419.0,70 Biggest Movers From Friday,2020-05-18 04:47:00-04:00,ALDX,neutral
58420.0,50 Stocks Moving In Friday's Mid-Day Session,2020-05-15 12:31:00-04:00,ALDX,neutral
58421.0,84 Biggest Movers From Yesterday,2020-05-13 05:31:00-04:00,ALDX,neutral
58422.0,60 Stocks Moving In Tuesday's Mid-Day Session,2020-05-12 12:26:00-04:00,ALDX,neutral
58423.0,"Benzinga's Top Upgrades, Downgrades For May 12, 2020",2020-05-12 09:51:00-04:00,ALDX,positive
58424.0,"Oppenheimer Initiates Coverage On Aldeyra Therapeutics with Outperform Rating, Announces Price Target of $12",2020-05-12 06:28:00-04:00,ALDX,neutral
58425.0,"The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500",2020-05-07 07:41:00-04:00,ALDX,negative
58426.0,Aldeyra Therapeutics Q1 EPS $(0.340) Beats $(0.480) Estimate,2020-05-07 07:12:00-04:00,ALDX,neutral
58427.0,The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace,2020-05-03 08:45:00-04:00,ALDX,neutral
58428.0,78 Biggest Movers From Yesterday,2020-04-15 04:45:00-04:00,ALDX,neutral
58429.0,Mid-Afternoon Market Update: NASDAQ Surges 4%; NeuroBo Pharmaceuticals Shares Plunge,2020-04-14 14:35:00-04:00,ALDX,positive
58430.0,55 Stocks Moving In Tuesday's Mid-Day Session,2020-04-14 12:52:00-04:00,ALDX,neutral
58431.0,Mid-Day Market Update: Crude Oil Down 5.5%; New Age Beverages Shares Jump,2020-04-14 12:18:00-04:00,ALDX,negative
58432.0,Mid-Morning Market Update: Markets Open Higher; JPMorgan Posts Lower Q1 Profit,2020-04-14 10:24:00-04:00,ALDX,positive
58433.0,Aldeyra Announces Top-Line Phase 1 Clinical Trial Results And Clinical Development Plans For ADX-629,2020-04-14 08:23:00-04:00,ALDX,neutral
58434.0,"The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates",2020-03-18 07:36:00-04:00,ALDX,positive
58435.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,ALDX,negative
58436.0,"The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO",2020-03-12 07:37:00-04:00,ALDX,negative
58437.0,"Aldeyra Therapeutics Reports Will Focus On Phase 3 Programs For Allergic Conjunctivitis, Dry Eye Disease, Proliferative Vitreoretinopathy",2020-03-12 07:02:00-04:00,ALDX,negative
58438.0,"The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment",2020-03-11 08:03:00-04:00,ALDX,positive
58439.0,Stocks That Hit 52-Week Lows On Tuesday,2020-03-10 10:37:00-04:00,ALDX,negative
58440.0,"The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index",2020-03-10 09:19:00-04:00,ALDX,negative
58441.0,"The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues",2020-03-08 16:14:00-04:00,ALDX,negative
58442.0,Stocks That Hit 52-Week Lows On Friday,2020-03-06 11:22:00-05:00,ALDX,negative
58443.0,"The Daily Biotech Pulse: Breakthrough Device Designation For Neuronetics, AbbVie Receives European Label Expansion, AstraZeneca Flunks Late-Stage Study",2020-03-06 08:49:00-05:00,ALDX,negative
58444.0,"The Daily Biotech Pulse: Takeda Jumps Into The COVID-19 Fray, Exact Sciences Buys Cancer Diagnostics Companies",2020-03-04 07:37:00-05:00,ALDX,negative
58445.0,Stocks That Hit 52-Week Lows On Friday,2020-02-28 10:16:00-05:00,ALDX,negative
58446.0,"The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO",2020-02-28 07:28:00-05:00,ALDX,neutral
58447.0,Stocks That Hit 52-Week Lows On Thursday,2020-02-27 10:23:00-05:00,ALDX,negative
58448.0,Aldeyra Therapeutics To Host R&D Day; Announces Primary Endpoint Of Symptom Control Achieved In Phase 2 Dry Eye Disease Formulation Trial,2020-02-24 08:24:00-05:00,ALDX,neutral
58449.0,146 Biotechnology Stocks Moving In Thursday's Session,2020-01-23 12:47:00-05:00,ALDX,neutral
58450.0,Aldeyra Therapeutics Announces First Patient Enrolled In Phase 3 INVIGORATE Trial In Allergic Conjunctivitis,2020-01-21 08:10:00-05:00,ALDX,positive
58451.0,60 Biggest Movers From Yesterday,2019-12-27 04:44:00-05:00,ALDX,neutral
58452.0,34 Stocks Moving In Thursday's Mid-Day Session,2019-12-26 12:11:00-05:00,ALDX,neutral
58453.0,Aldeyra Therapeutics Reports First Patient Enrolled In Phase 3 GUARD Trial For Prevention Of Proliferative Vitreoretinopathy,2019-12-19 08:02:00-05:00,ALDX,neutral
58454.0,63 Biggest Movers From Yesterday,2019-12-04 05:15:00-05:00,ALDX,neutral
58455.0,40 Stocks Moving In Tuesday's Mid-Day Session,2019-12-03 12:20:00-05:00,ALDX,neutral
58456.0,Mid-Morning Market Update: Markets Open Lower; Cleveland-Cliffs To Acquire AK Steel For $3.36/Share,2019-12-03 10:11:00-05:00,ALDX,negative
58457.0,"The Daily Biotech Pulse: Astellas To Buy Audentes For $3B, Applied Genetics Chief Medical Officer Quits, Axsome Aces Midstage Trial",2019-12-03 07:59:00-05:00,ALDX,neutral
58458.0,19 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-12-03 07:46:00-05:00,ALDX,neutral
58459.0,Aldeyra Therapeutics Announces Top-Line Results From Part 1 of Adaptive Phase 3 RENEW Trial In Dry Eye Disease,2019-12-03 07:18:00-05:00,ALDX,neutral
58460.0,Aldeyra Therapeutics Q3 EPS $(0.69) Misses $(0.55) Estimate,2019-11-07 08:20:00-05:00,ALDX,negative
58461.0,"The Daily Biotech Pulse: Obseva Sinks On Adverse Clinical Readout, BioNano Surges On Saphyr Adoption, 2 IPOs",2019-11-07 07:18:00-05:00,ALDX,negative
58462.0,"Mid-Afternoon Market Update: US Markets Down, Dow Loses More Than 200 Points",2019-10-31 14:57:00-04:00,ALDX,negative
58463.0,27 Stocks Moving In Thursday's Mid-Day Session,2019-10-31 11:51:00-04:00,ALDX,neutral
58464.0,Mid-Day Market Update: Markets Dip After Morning Rise; Oil Plunges,2019-10-31 11:35:00-04:00,ALDX,neutral
58465.0,Mid-Morning Market Update: Markets Inch Up; Bristol-Myers Squibb Reports Q3 Beat,2019-10-31 09:56:00-04:00,ALDX,neutral
58466.0,15 Stocks Moving in Thursday's Pre-Market Session,2019-10-31 09:32:00-04:00,ALDX,neutral
58467.0,"Aldeyra Therapeutics Shares Resume Trade, Up 13%",2019-10-31 07:40:00-04:00,ALDX,positive
58468.0,Aldeyra Therapeutics Shares To Resume Trade At 7:30 a.m. EDT,2019-10-31 07:23:00-04:00,ALDX,positive
58469.0,Aldeyra Therapeutics Reports Expanded Results From Co.'s Allergen Chamber Clinical Methods Trial; Says Will Initiate Phase 3 INVIGORATE Trial In Patients With Allergic Conjunctivitis,2019-10-31 07:22:00-04:00,ALDX,positive
58470.0,Aldeyra Therapeutics Shares Halted News Pending,2019-10-31 06:58:00-04:00,ALDX,positive
58471.0,"Cantor Fitzgerald Assumes Aldeyra Therapeutics at Overweight, Announces $33 Price Target",2019-10-22 09:33:00-04:00,ALDX,negative
58472.0,63 Biggest Movers From Yesterday,2019-10-16 04:04:00-04:00,ALDX,neutral
58473.0,"4 Stocks To Watch For October 14, 2019",2019-10-14 03:51:00-04:00,ALDX,neutral
58474.0,"The Week Ahead In Biotech: FDA Decisions, Johnson & Johnson Among Big Pharma Earnings",2019-10-13 16:33:00-04:00,ALDX,neutral
58475.0,46 Biggest Movers From Yesterday,2019-10-03 05:05:00-04:00,ALDX,neutral
58476.0,Aldeyra Reports Will Present Phase 3 ALLEVIATE Trial Results In Allergic Conjunctivitis At American Academy of Ophthalmology,2019-09-26 08:04:00-04:00,ALDX,negative
58477.0,Aldeyra Therapeutics Receives Fast Track Designation For ADX-2191 For The Prevention Of Proliferative Vitreoretinopathy,2019-09-24 08:05:00-04:00,ALDX,neutral
58478.0,80 Biggest Movers From Yesterday,2019-09-11 05:11:00-04:00,ALDX,neutral
58479.0,"The Daily Biotech Pulse: EC Nod For Bristol-Myers Squibb, Kyowa Kirin's Parkinson's Add-On Therapy Approved",2019-08-28 07:31:00-04:00,ALDX,positive
58480.0,Stocks That Hit 52-Week Lows On Monday,2019-08-26 10:28:00-04:00,ALDX,negative
58481.0,Stocks That Hit 52-Week Lows On Friday,2019-08-16 11:44:00-04:00,ALDX,negative
58482.0,"The Daily Biotech Pulse: Roche Snags Double Nod For Personalized Cancer Drug, Bellicum Offering, Nabriva Braces For Contepo Resubmission",2019-08-16 07:33:00-04:00,ALDX,negative
58483.0,"Aldeyra Therapeutics Earlier Reported Q2 EPS $(0.49), Inline",2019-08-08 11:13:00-04:00,ALDX,neutral
58484.0,"The Daily Biotech Pulse: Decision Day For Regeneron-Sanofi, Vermillion Offering, PDL BioPharma CFO to Depart",2019-06-26 07:19:00-04:00,ALDX,neutral
58485.0,51 Biggest Movers From Yesterday,2019-06-26 05:53:00-04:00,ALDX,neutral
58486.0,42 Stocks Moving In Tuesday's Mid-Day Session,2019-06-25 12:44:00-04:00,ALDX,neutral
58487.0,Mid-Morning Market Update: Markets Open Lower; Lennar Tops Q2 Estimates,2019-06-25 10:15:00-04:00,ALDX,positive
58488.0,No Solace For Aldeyra As Late-Stage Study Of Lead Drug In Anterior Uveitis Fails,2019-06-25 09:26:00-04:00,ALDX,negative
58489.0,30 Stocks Moving In Tuesday's Pre-Market Session,2019-06-25 08:04:00-04:00,ALDX,neutral
58490.0,Aldeyra Therapeutics Shares Resume Trade,2019-06-25 07:30:00-04:00,ALDX,positive
58491.0,Aldeyra Therapeutics shares are trading lower after the company announced its SOLACE trial in noninfectious anterior uveitis did not achieve statistical significance in its primary or secondary endpoints.,2019-06-25 07:30:00-04:00,ALDX,negative
58492.0,"The Daily Biotech Pulse: Genfit NASH Drug In China, Conatus Explores Sale, Gilead Stitches Up Immuno-Oncology Partnership",2019-06-25 07:15:00-04:00,ALDX,neutral
58493.0,Aldeyra Therapeutics Shares To Resume Trade At 7:30 a.m. EDT,2019-06-25 07:05:00-04:00,ALDX,positive
58494.0,Aldeyra Therapeutics Announces SOLACE Trial In Noninfectious Anterior Uveitis Did Not Achieve Statistical Significance In Its Primary Or Secondary Endpoints,2019-06-25 07:01:00-04:00,ALDX,negative
58495.0,"Aldeyra Therapeutics Shares Halted, News Pending",2019-06-25 06:58:00-04:00,ALDX,positive
58496.0,"The Daily Biotech Pulse: ASCO Presentations From Roche, Celgene & More, Edwards Recommends Rejection Of Mini-Tender Offer",2019-06-04 07:45:00-04:00,ALDX,negative
